Nielsen BioSciences, Inc. is a San Diego-based biopharmaceutical company specializing in the development and commercialization of biological products that activate cell-mediated immune responses. Their innovative immunotherapies, such as CANDIN and Spherusol, have shown promising results in clinical trials for the treatment and detection of various conditions, including human papilloma virus (HPV) infections, common warts, and coccidioidomycosis (Valley Fever). With a focus on assessing cellular hypersensitivity and immune competence, Nielsen BioSciences aims to provide effective solutions for patients and healthcare professionals in need of advanced diagnostic tools and therapeutic options.
Generated from the website